Biosite Incorporated

Biosite Incorporated's subsidiary, Cholestech, is a leading provider of diagnostic tools and information for health care practitioners worldwide. The company offers a range of diagnostic testing for cholesterol, lipids, blood glucose, liver enzymes, and glycemic control, as well as risk assessment and therapeutic monitoring solutions for heart disease and diabetes. Its FDA-approved products, including the Cholestech LDX and Cholestech GDX systems, are used for monitoring patient therapy progress. The Cholestech GDX system, in particular, provides hemoglobin A1C testing to indicate blood sugar control over the last two and three months. Cholestech's products are distributed in over 35 countries, including the United States, Europe, Asia, South America, and Australia.